@techcrunch.com 2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com 4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com 4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@Primary_Immune 4 years ago
Passing the blood-#brain barrier could allow Rx of a myriad of diseases -Scientists believe they have cracked one of Medicine's most difficult challenges https://www.ncl.ac.uk/press/articles/latest/2019/10/blood-brain-barrier/ #Scicomm #OpenScience #technology #biotech #SNRTG #neurology #neuroscience #RareDisease #BigData #IoT https://t.co/y77hbmOExP
@xconomy.com 5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@techcrunch.com 5 years ago
RDMD attacks rare diseases with data mined from health records
@xconomy.com 5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@Primary_Immune 6 years ago
Magic Is Not Going to Bring Cures for Devastating Diseases - THANK YOU to All Working Diligently In Labs to Advance Medical Science! https://twitter.com/neiltyson/status/981128434641395712 #genetics #BigData #genomics #science #innovation #technology #ChildhoodCancer #RareDisease #pharma #biotech #STEM
@techcrunch.com 6 years ago
Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics
@venturebeat.com 7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs